Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001601830-24-000176

Chief Financial Officer sold 30,000 shares at an average $6.34 ($190,131)

  • Chief Financial Officer acquired 78,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Secora Michael · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-08 Exercise or conversion : show line 1 in the form 10b5-1 +39,375 $2.22 $87,413 1,441,506 D
2024-10-08 Sale : show line 2 in the form 10b5-1 −15,000 $6.32 $94,757 1,426,506 D
2024-10-09 Exercise or conversion : show line 3 in the form 10b5-1 +39,375 $2.22 $87,413 1,465,881 D
2024-10-09 Sale : show line 4 in the form 10b5-1 −15,000 $6.36 $95,375 1,450,881 D
Open-market sales · 30,000 sh · avg $6.34 · $190,131

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-10-08 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −39,375 455,760 D
2024-10-09 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −39,375 416,385 D
Loading xslF345X05/wk-form4_1728600038.xml…